Search Results - Jeremy R. Jackson
- Showing 1 - 4 results of 4
-
1
-
2
<scp>C</scp>olony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes by Matthew W. Webb, Jianping Sun, Michael A. Sheard, Wei‐Yao Liu, Hongwei Wu, Jeremy R. Jackson, Jemily Malvar, Richard Sposto, Dylan Daniel, Robert C. Seeger
Published 2018Artigo -
3
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma by Wesley E. Barry, Jeremy R. Jackson, Grace E. Asuelime, Hongwei Wu, Jianping Sun, Zesheng Wan, Jemily Malvar, Michael A. Sheard, Larry Wang, Robert C. Seeger, Eugene S. Kim
Published 2018Artigo -
4
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells by Hung C. Tran, Zesheng Wan, Michael A. Sheard, Jianping Sun, Jeremy R. Jackson, Jemily Malvar, Yibing Xu, Larry Wang, Richard Sposto, Eugene S. Kim, Shahab Asgharzadeh, Robert C. Seeger
Published 2016Artigo
Search Tools:
Related Subjects
Biochemistry
Biology
Cancer research
Cell culture
Genetics
Neuroblastoma
In vitro
Medicine
Chemistry
Cytotoxic T cell
Cytotoxicity
Immunology
Internal medicine
Angiogenesis
Antibody-dependent cell-mediated cytotoxicity
Apoptosis
Biotechnology
Blockade
Cancer
Chemotherapy
Immunotherapy
In vivo
Mdm2
Molecular biology
NKG2D
Pathology
Pharmacology
Receptor
VEGF receptors
Vascular endothelial growth factor